Roche: WHO prequalification for HPV testing
This pre-qualification enables low- and middle-income countries to use these screening solutions, including self-collection, in their national cervical cancer elimination programs, significantly improving access.
Every year, more than 600,000 women worldwide are diagnosed with cervical cancer, and more than 340,000 die from this preventable disease caused by HPV infection", the Swiss healthcare group points out.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction